Related Experiment Video
Updated: May 2, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
Runx1-mediated regulation of osteoclast differentiation and function
Do Y Soung1, Judith Kalinowski, Sanjeev K Baniwal
1New England Musculoskeletal Institute (D.Y.S., J.K., C.E.J.-G., J.L., H.D.), Department of Orthopaedic Surgery (H.D.), and Department of Medicine (C.E.J.-G.), University of Connecticut Health Center, Farmington, Connecticut 06030; and Department of Orthopaedic Surgery and Biochemistry and Molecular Biology (S.K.B., B.F.), University of Southern California, Los Angeles, California 90089.
Runx1, a key regulator in blood cell development, was found to inhibit osteoclast formation and activity. Its absence in preosteoclasts leads to reduced bone mass and increased bone resorption, highlighting its role in skeletal health.
Area of Science:
- Bone Biology
- Hematopoiesis
- Metabolic Bone Diseases
Background:
- Excessive bone resorption causes metabolic bone diseases like osteoporosis.
- Runx1, a master regulator of hematopoiesis, is present in preosteoclasts and may impact skeletal health.
- Identifying factors inhibiting osteoclast activity can lead to new osteoporosis therapies.
Purpose of the Study:
- To investigate the role of Runx1 in osteoclast formation and function.
- To determine if Runx1 deficiency in myeloid precursors affects bone mass and resorption.
Main Methods:
- Created mice lacking Runx1 in myeloid osteoclast precursors (CD11b-Cre;Runx1(F/F)).
- Compared bone mass, serum resorption biomarkers, and in vitro osteoclast activity between knockout and control mice.
- Analyzed mRNA levels of key osteoclast-related genes.
Main Results:
- Runx1-deficient mice showed significant loss of trabecular and cortical bone.
- Serum levels of bone resorption biomarkers were elevated in Runx1-deficient mice.
- Osteoclasts from Runx1-deficient mice were larger, more numerous, and had increased resorbing activity with elevated expression of key osteoclast genes.
Conclusions:
- Runx1 expression in preosteoclasts negatively regulates osteoclast formation and activity.
- Runx1 plays a crucial role in maintaining overall bone mass.
- Runx1 is a potential therapeutic target for metabolic bone diseases characterized by excessive bone resorption.
Related Concept Videos
Osteoclasts in Bone Remodeling
Master Transcription Regulators
Bone Remodeling
Regulation of Angiogenesis and Blood Supply
Regulation of Expression at Multiple Steps
TGF - β Signaling Pathway

